Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) Director Wayne A.I. Frederick sold 3,000 shares of the firm's stock in a transaction dated Monday, March 31st. The stock was sold at an average price of $45.54, for a total value of $136,620.00. Following the sale, the director now directly owns 26,514 shares in the company, valued at approximately $1,207,447.56. This trade represents a 10.16 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.
Tempus AI Trading Up 5.7 %
Shares of Tempus AI stock opened at $49.89 on Thursday. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. The business has a 50 day simple moving average of $58.62 and a two-hundred day simple moving average of $51.55. Tempus AI, Inc. has a 12 month low of $22.89 and a 12 month high of $91.45.
Wall Street Analysts Forecast Growth
TEM has been the topic of several recent research reports. Guggenheim restated a "buy" rating on shares of Tempus AI in a research report on Tuesday, February 25th. TD Cowen restated a "buy" rating and set a $74.00 price target (up previously from $58.00) on shares of Tempus AI in a research report on Wednesday, February 5th. JPMorgan Chase & Co. cut shares of Tempus AI from an "overweight" rating to a "neutral" rating and lifted their price objective for the company from $50.00 to $55.00 in a report on Tuesday, February 25th. Piper Sandler lowered their target price on shares of Tempus AI from $70.00 to $55.00 and set a "neutral" rating on the stock in a research note on Tuesday, March 4th. Finally, William Blair restated a "market perform" rating on shares of Tempus AI in a research note on Tuesday, February 25th. Six analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $61.18.
Check Out Our Latest Stock Analysis on TEM
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. GF Fund Management CO. LTD. acquired a new stake in shares of Tempus AI in the fourth quarter valued at about $108,000. Voloridge Investment Management LLC purchased a new stake in Tempus AI during the 4th quarter valued at about $11,826,000. Two Sigma Advisers LP acquired a new stake in Tempus AI in the 4th quarter valued at about $625,000. ProShare Advisors LLC purchased a new position in Tempus AI in the 4th quarter worth approximately $244,000. Finally, Lazard Asset Management LLC acquired a new position in shares of Tempus AI during the 4th quarter worth approximately $1,034,000. Hedge funds and other institutional investors own 24.22% of the company's stock.
About Tempus AI
(
Get Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.
